USANA Health Sciences (USNA) investor files Rule 144 notice to sell $56K in stock

Rhea-AI Filing Summary

USANA Health Sciences filed a notice under Rule 144 for a planned sale of restricted common stock. The filing covers 2,673 shares of common stock, with an aggregate market value of $56,000.95, to be sold through Morgan Stanley Smith Barney LLC on the NYSE. The issuer had 18,280,857 shares of common stock outstanding. The shares were acquired from the issuer as restricted stock in several transactions dated between February 6, 2025 and July 25, 2025. The seller represents that they are not aware of any material adverse, nonpublic information about the company’s current or prospective operations.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	2673	56000.95	18280857	12/10/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/08/2025	Restricted Stock	Issuer			756	02/08/2025	Not Applicable
Common	02/06/2025	Restricted Stock	Issuer			654	02/06/2025	Not Applicable
Common	02/07/2025	Restricted Stock	Issuer			412	02/07/2025	Not Applicable
Common	07/25/2025	Restricted Stock	Issuer			422	07/25/2025	Not Applicable
Common	02/08/2025	Restricted Stock	Issuer			429	02/08/2025	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filing for USNA disclose?

The Form 144 discloses that a holder of USANA Health Sciences (USNA) common stock intends to sell restricted shares under Rule 144, including key details such as the number of shares, market value, and broker.

How many USNA shares are covered by this Form 144 notice and what is their value?

The notice covers 2,673 shares of USNA common stock with an aggregate market value of $56,000.95, to be sold on the NYSE through Morgan Stanley Smith Barney LLC.

How many USANA Health Sciences shares were outstanding at the time referenced?

The filing states that 18,280,857 shares of USANA Health Sciences common stock were outstanding for the class referenced in the notice.

How and when were the USNA shares in this Form 144 acquired?

The shares were acquired from the issuer as restricted stock in multiple transactions dated February 6, 7, 8, 2025 and July 25, 2025, with various amounts on each date.

What does the Form 144 filer represent about nonpublic information on USNA?

The person for whose account the securities are to be sold represents that they do not know any material adverse information about USANA Health Sciences’ current or prospective operations that has not been publicly disclosed.

Which broker is handling the planned sale of USNA shares under this Form 144?

The planned sale of USANA Health Sciences common stock is to be handled by Morgan Stanley Smith Barney LLC Executive Financial Services, with sales expected to occur on the NYSE.